Investing Port

P/E	669.87
P/S	8.96
P/BV	10.86
EV/EBITDA	58.59
EBITDA	0.2402
Цена ао	45.97

Все параметры ⇨

		Недооценка Название Значение Оценка P/S 8.96 1 P/BV 10.86 1 P/E 669.87 1 EV/EBITDA 58.59 1	Эффективность Название Значение Оценка ROA, % 2.18 1 ROE, % -0.64 1
	Дивиденды Название Значение Оценка Div yield, % 0 DSI 0 0	Долг Название Значение Оценка Долг/EBITDA 0	Импульс роста Название Значение Оценка Рост прибыли, % 0 0 Рост цены акции, % 0 0 Рост дивидендов, % 0 0

Дивиденды, %	Дивиденды	По итогам периода	Дата закрытия реестра	Купить до	Выплата до
4.47	2.2	III кв. 2019	02.10.2019	30.09.2019	17.10.2019

Institutions	Объем	Доля, %
Invesco Advisers, Inc.	4728710	1.66
Boston Company Asset Mgmt, LLC	415371	0.15
First Trust Portfolios L.P.	36468	0.01
USA Financial Formulas	15196	0.01
David J. Greene and Company, LLC	278300	0.1
Hennion & Walsh, Inc	200	0
Legg Mason Partners Fund Advisor, LLC	16676968	5.85
Purpose Investments Inc.	45022	0.02
Stewart Capital Advisors, LLC	133348	0.05
RGM Capital LLC	4354603	1.53
Principal Global Investors, LLC	1781829	0.63
12th Street Asset Management, LLC	929074	0.33
FIL Fund Management Limited	400719	0.14
Contour Asset Management LLC	5273554	1.85
Nuveen Fund Advisors, LLC.	704123	0.25
Wells Fargo Funds Management LLC	2689710	0.94
ClearBridge Investments, LLC.	7869097	2.76
Formula Growth Ltd	948500	0.33
Neuberger Berman	642236	0.23
Southpoint Capital Advisors LP	7550000	2.65
BNY Mellon Investment Adviser, Inc.	2669689	0.94
AlphaCentric Advisors LLC	70000	0.02
Thrivent Asset Management, LLC	5979613	2.1
Global X Management Company LLC	818779	0.29
Hennion & Walsh, Inc	200	0
Hartford Funds Management Company, LLC	254572	0.09
Mellon Investments Corporation	95864	0.03
Invesco Capital Management LLC	1149852	0.4
Fidelity Management & Research Company LLC	16437952	5.77

ETF	Доля, %	Доходность за год, %	Дивиденды, %
Global X Telemedicine & Digital Health ETF	4.72		0.03
Invesco PureBetaSM MSCI USA Small Cap ETF	0.28	47.95	1.29
Vanguard Small Cap Value ETF	0.48	33.55	1.47

Nuance Communications, Inc. provides conversational artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. It offers customers high accuracy in automated speech recognition, natural language understanding capabilities, dialog and information management, biometric speaker authentication, text-to-speech, and domain knowledge along with professional services and implementation support. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, Web, and messaging channels. Its Other segment provides voicemail transcription services to mobile operators. The company serves organizations across healthcare, financial services, telecommunications, government, and retail. Nuance Communications, Inc. markets and sells its solutions and technologies directly through sales force, as well as through a network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, telecommunications carriers, and e-commerce Website worldwide. Nuance Communications, Inc. has a strategic partnerships with Mila to collaborate on research and advance work in machine learning; and Providence to improve patient and caregiver experience. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts.